Key result
ICI myocarditis and CHIP converge on shared inflammatory pathways including JAK-STAT and IL-17 signaling.
Why the study?
Immune checkpoint inhibitor (ICI) myocarditis carries up to 50% mortality and is linked to clonal hematopoiesis of indeterminate potential (CHIP). This study evaluated cytokines, implicated pathways, and cell-type contributions associated with ICI myocarditis, immunosuppression resistance, and CHIP.
What cytokine signatures, molecular pathways, and single-cell transcriptional programs are associated with immune checkpoint inhibitor myocarditis and modified by clonal hematopoiesis in cardio-oncology patients?
Cohort (n=236)
Yes
What cytokine signatures, molecular pathways, and single-cell transcriptional programs are associated with immune checkpoint inhibitor myocarditis and modified by clonal hematopoiesis in cardio-oncology patients?
Identifies JAK-STAT signaling as a convergent, potentially actionable pathway in immune checkpoint inhibitor myocarditis that is amplified in clonal hematopoiesis carriers, supporting future evaluation of cytokine-guided risk stratification and JAK-STAT-directed immunosuppression.
Answers are grounded in this paper and cite their sources.
JAK-STAT activation in ICI myocarditis with CHIP supports targeted validation; leaves open whether pathway inhibition alters outcomes in cardio-oncology.
Background Immune checkpoint inhibitor (ICI) myocarditis affects up to 2% of patients on ICI and has up to a 50% mortality. Clonal Hematopoiesis of Indeterminate Potential (CHIP) is a risk factor for ICI myocarditis. Objectives: To leverage a multi-omics approach to evaluate cytokines associated with ICI myocarditis, immunosuppression resistance, CHIP in ICI myocarditis and implicated pathways and cell type contributions. Methods 236 cardio-oncology patients were enrolled, including 88 who were on ICI. Cytokine profiling from patients on ICI were sampled and analyzed using machine learning and explainable artificial intelligence. Single-cell multi-omics of peripheral blood from Yale (n=19), Stanford (n=25), and MGH (n=63) evaluated cell-type contributions of cytokines and implicated pathways. Validation of Yale proteomic analyses was done using the Stanford CYTOF dataset. Results Top features associated with ICI myocarditis included IL13, CXCL10, PDGFA, CCL13, CCL17 and KITlg. Top KEGG pathways associated with ICI myocarditis and immunosuppression resistant ICI myocarditis included JAK STAT signaling, IL17 signaling and lipid/atherosclerosis pathways. At the single-cell level, the consensus signals distinguishing myocarditis from non-myocarditis across cohorts was predominantly driven by module-level JAK STAT, T cell, and Toll like receptor activation. Similar transcription gene programs were activated in CHIP carriers including modules implicated in the pro-inflammatory immune response, such as NF kappa B, IL17, MAPK, and TNF pathways within CHIP cells spanning lymphoid (cytotoxic CD8+ NKT, and natural killer cells) and myeloid lineages. Conclusions Across cohorts, JAK STAT signaling emerges as a convergent and potentially actionable axis in ICI myocarditis that is further amplified in CHIP carriers, supporting cytokine-guided risk stratification and JAK STAT directed immunosuppression as testable strategies.
No takes yet. Share an insight, caveat, or question.
Manchanda et al. (2026) conducted a cohort in Immune checkpoint inhibitor (ICI) myocarditis in cardio-oncology patients (n=236). Immune checkpoint inhibitor therapy and Clonal Hematopoiesis of Indeterminate Potential (CHIP) carrier status vs. Non-myocarditis patients and non-CHIP carriers was evaluated on Cytokine signatures, KEGG pathways, and single-cell gene programs associated with ICI myocarditis and immunosuppression resistance. In 236 cardio-oncology patients (88 on ICI), ICI myocarditis and CHIP were associated with convergent activation of JAK-STAT, IL-17, T-cell, and TLR signaling pathways.
Synapse has enriched 10 related papers. Consider them for comparative context: